المؤلفون: Galbusera, M., Bresin, E., Noris, M., Gastoldi, S., Belotti, D., Capoferri, C., Daina, E., Perseghin, P., Scheiflinger, F., Fakhouri, F., Grunfeld, J. P., Pogliani, E., Remuzzi, G.

المصدر: Blood, vol. 106, no. 3, pp. 925-8

مصطلحات موضوعية: ADAM Proteins, ADAMTS13 Protein, Antibodies, Monoclonal/*therapeutic use, Monoclonal, Murine-Derived, Autoantibodies/blood/drug effects, Humans, Immunoassay, Male, Metalloendopeptidases/immunology, Middle Aged, Plasma Exchange, Purpura, Thrombotic Thrombocytopenic/*drug therapy/therapy, Rituximab, Secondary Prevention, von Willebrand Factor/analysis

Relation: info:eu-repo/semantics/altIdentifier/pmid/15827129; info:eu-repo/semantics/altIdentifier/pissn/0006-4971; https://serval.unil.ch/notice/serval:BIB_C2C0E6F1D749

الاتاحة: https://serval.unil.ch/notice/serval:BIB_C2C0E6F1D749
https://doi.org/10.1182/blood-2004-12-4885